Literature DB >> 20231390

Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.

Matthew G Blango1, Matthew A Mulvey.   

Abstract

Numerous antibiotics have proven to be effective at ameliorating the clinical symptoms of urinary tract infections (UTIs), but recurrent and chronic infections continue to plague many individuals. Most UTIs are caused by strains of uropathogenic Escherichia coli (UPEC), which can form both extra- and intracellular biofilm-like communities within the bladder. UPEC also persist inside host urothelial cells in a more quiescent state, sequestered within late endosomal compartments. Here, we tested a panel of 17 different antibiotics, representing seven distinct functional classes, for their effects on the survival of the reference UPEC isolate UTI89 within both biofilms and host bladder urothelial cells. All but one of the tested antibiotics prevented UTI89 growth in broth culture, and most were at least modestly effective against bacteria present within in vitro-grown biofilms. In contrast, only a few of the antibiotics, including nitrofurantoin and the fluoroquinolones ciprofloxacin and sparfloxacin, were able to eliminate intracellular bacteria in bladder cell culture-based assays. However, in a mouse UTI model system in which these antibiotics reached concentrations in the urine specimens that far exceeded minimal inhibitory doses, UPEC reservoirs in bladder tissues were not effectively eradicated. We conclude that the persistence of UPEC within the bladder, regardless of antibiotic treatments, is likely facilitated by a combination of biofilm formation, entry of UPEC into a quiescent or semiquiescent state within host cells, and the stalwart permeability barrier function associated with the bladder urothelium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231390      PMCID: PMC2863638          DOI: 10.1128/AAC.00014-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  62 in total

Review 1.  Structure and function of Escherichia coli type 1 pili: new insight into the pathogenesis of urinary tract infections.

Authors:  J D Schilling; M A Mulvey; S J Hultgren
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

Review 2.  Antibiotic resistance of bacteria in biofilms.

Authors:  P S Stewart; J W Costerton
Journal:  Lancet       Date:  2001-07-14       Impact factor: 79.321

3.  Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women.

Authors:  T Kontiokari; K Sundqvist; M Nuutinen; T Pokka; M Koskela; M Uhari
Journal:  BMJ       Date:  2001-06-30

4.  Type 1 pilus-mediated bacterial invasion of bladder epithelial cells.

Authors:  J J Martinez; M A Mulvey; J D Schilling; J S Pinkner; S J Hultgren
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

5.  Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

Authors:  M A Mulvey; J D Schilling; S J Hultgren
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up.

Authors:  U M Kärkkäinen; R Ikäheimo; M L Katila; A Siitonen
Journal:  Scand J Infect Dis       Date:  2000

Review 7.  Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.

Authors:  M A Mulvey; J D Schilling; J J Martinez; S J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

8.  Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.

Authors:  H Hvidberg; C Struve; K A Krogfelt; N Christensen; S N Rasmussen; N Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.

Authors:  G Elhanan; H Tabenkin; R Yahalom; R Raz
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

10.  Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding.

Authors:  G Zhou; W J Mo; P Sebbel; G Min; T A Neubert; R Glockshuber; X R Wu; T T Sun; X P Kong
Journal:  J Cell Sci       Date:  2001-11       Impact factor: 5.285

View more
  118 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

3.  Antibacterial effects of nitric oxide on uropathogenic Escherichia coli during bladder epithelial cell colonization--a comparison with nitrofurantoin.

Authors:  Ravi Vumma; Charlotte Sahlberg Bang; Robert Kruse; Kjell Johansson; Katarina Persson
Journal:  J Antibiot (Tokyo)       Date:  2015-11-04       Impact factor: 2.649

Review 4.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

5.  Escherichia coli biofilm formation and recurrences of urinary tract infections in children.

Authors:  T Tapiainen; A-M Hanni; J Salo; I Ikäheimo; M Uhari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-02       Impact factor: 3.267

6.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

7.  Similarity and divergence of phylogenies, antimicrobial susceptibilities, and virulence factor profiles of Escherichia coli isolates causing recurrent urinary tract infections that persist or result from reinfection.

Authors:  Yanping Luo; Yanning Ma; Qiang Zhao; Leili Wang; Ling Guo; Liyan Ye; Youjiang Zhang; Jiyong Yang
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

8.  Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.

Authors:  Luciana Robino; Paola Scavone; Lucia Araujo; Gabriela Algorta; Pablo Zunino; María Catalina Pírez; Rafael Vignoli
Journal:  Clin Infect Dis       Date:  2014-08-04       Impact factor: 9.079

9.  Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies.

Authors:  Shu-Cheng Liu; Xiao-Min Han; Ming Shi; Zi-Li Pang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

10.  The Cpx stress response system potentiates the fitness and virulence of uropathogenic Escherichia coli.

Authors:  Irina Debnath; J Paul Norton; Amelia E Barber; Elizabeth M Ott; Bijaya K Dhakal; Richard R Kulesus; Matthew A Mulvey
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.